Literature DB >> 14635320

Test characteristics of immunofluorescence and ELISA tests in 856 consecutive patients with possible ANCA-associated conditions.

J H Stone1, M Talor, J Stebbing, M L Uhlfelder, N R Rose, K A Carson, D B Hellmann, C L Burek.   

Abstract

OBJECTIVE: To examine the test characteristics of immunofluorescence (IF) and enzyme-linked immunosorbent assays (ELISA) in a consecutive series of patients under evaluation for anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).
METHODS: Using stored sera, we performed a cross-sectional study on 856 consecutive patients tested prospectively for ANCA by IF, Based on guidelines from the 1994 Chapel Hill Consensus Conference (CHCC), we determined each patient's underlying diagnosis by a medical records review without regard to their ANCA status (the CHCC guidelines do not require ANCA as a prerequisite for diagnosis). We grouped patients with forms of vasculitis commonly associated with ANCA into one of 4 types of AAV: Wegener's granulomatosis (n = 45), microscopic polyangiitis (n = 12), Churg-Strauss syndrome (n = 4), and pauci-immune glomerulonephritis (n = 8). We also classified patients without clinical evidence of AAV (92% of all patients tested) into 5 predefined categories of disease (including "other") and an additional category for no identifiable disease. In a blinded fashion, we then performed ELISAs on the stored serum for antibodies to proteinase-3 (PR3) and myeloperoxidase (MPO) and calculated the test characteristics for both ANCA assay techniques.
RESULTS: Sixty-nine of the 856 patients (8.1%) had clinical diagnoses of AAV based on CHCC guidelines. The positive predictive value (PPV) of ELISA for AAV was superior to that of IF, 83% versus 45%. For patients with both positive IF tests and positive ELISA tests, the PPV increased to 88%. Both IF and ELISA had high negative predictive values (97% and 96%, respectively). Positive ELISA tests were associated with higher likelihood ratios (LR) than IF (54.2 [95% CI = 26.3, 111.5] versus 9.4 [95% CI = 6.9, 12.7]). The LR of both a positive IF and a positive ELISA was 82.1 (95% CI = 33.3, 202.5).
CONCLUSIONS: Compared with IF, an ELISA test fo ANCA was associated with a substantially higher PPV and LR for AAV. This fact, combined with the greater sensitivity of IF, suggests that an effective testing strategy is to perform ELISA tests only on samples that are positive for ANCA by IF.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 14635320     DOI: 10.1002/1529-0131(200012)13:6<424::aid-art14>3.0.co;2-q

Source DB:  PubMed          Journal:  Arthritis Care Res        ISSN: 0893-7524


  21 in total

1.  Myeloperoxidase-antineutrophil Cytoplasmic Antibodies (MPO-ANCA) and Proteinase 3-ANCA without Immunofluorescent ANCA Found by Routine Clinical Testing.

Authors:  Deepak A Rao; Kevin Wei; Joseph F Merola; William R O'Brien; Samuel U Takvorian; Paul F Dellaripa; Peter H Schur
Journal:  J Rheumatol       Date:  2015-04-01       Impact factor: 4.666

2.  Isolated eosinophilic mesenteric vasculitis with extensive thrombosis and splenic infarction in a 13-year-old boy.

Authors:  Amal Abdulwahab; Hani Almoallim; Nasim Khan
Journal:  Clin Rheumatol       Date:  2005-12-07       Impact factor: 2.980

Review 3.  Classification of the vasculitides: are they clinically useful?

Authors:  Ana M Bertoli; Graciela S Alarcón
Journal:  Curr Rheumatol Rep       Date:  2005-08       Impact factor: 4.592

4.  How could we make a diagnosis of Wegener's granulomatosis?

Authors:  Shuang Ye; Cheng-de Yang
Journal:  Clin Rheumatol       Date:  2006-01-21       Impact factor: 2.980

Review 5.  Diagnostic approach to patients with suspected vasculitis.

Authors:  E Suresh
Journal:  Postgrad Med J       Date:  2006-08       Impact factor: 2.401

Review 6.  Microscopic polyangiitis.

Authors:  Sharon A Chung; Philip Seo
Journal:  Rheum Dis Clin North Am       Date:  2010-06-11       Impact factor: 2.670

Review 7.  Anti-neutrophil cytoplasmic antibodies and their clinical significance.

Authors:  Supaporn Suwanchote; Muanpetch Rachayon; Pongsawat Rodsaward; Jongkonnee Wongpiyabovorn; Tawatchai Deekajorndech; Helen L Wright; Steven W Edwards; Michael W Beresford; Pawinee Rerknimitr; Direkrit Chiewchengchol
Journal:  Clin Rheumatol       Date:  2018-03-10       Impact factor: 2.980

8.  Clinical Implication of Proteinase-3-antineutrophil Cytoplasmic Antibody in Patients with Idiopathic Interstitial Pneumonias.

Authors:  Hironao Hozumi; Noriyuki Enomoto; Yoshiyuki Oyama; Masato Kono; Tomoyuki Fujisawa; Naoki Inui; Yutaro Nakamura; Takafumi Suda
Journal:  Lung       Date:  2016-02-12       Impact factor: 2.584

9.  Audit of the clinical usefulness of a rapid qualitative ELISA screen for antimyeloperoxidase and antiproteinase 3 antibodies in the assessment of patients with suspected vasculitis.

Authors:  A Aslam; T L Newman; S A Misbah
Journal:  J Clin Pathol       Date:  2003-10       Impact factor: 3.411

Review 10.  Renal involvement in Wegener's granulomatosis.

Authors:  Y Renaudineau; Y Le Meur
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.